Moreover, knockdown of the expression of AR in LNCaP and 22Rv1 cells resulted in abrogation of melatonin receptor-mediated cell proliferation inhibition, indicating that the antiproliferative signaling pathway activated by melatonin in human prostate cancer cells is AR-dependent [30]. The gene discussed is AR; the disease is prostate cancer.